USP17L2 and cancer: Co-injection of macrophages resulted in in faster tumor growth compared with the injection of cancer cells alone, even when only 70% of cancer cells were coinjected (Fig. 2d), and also resulted in the upregulation of USP17 and inflammation-associated genes in tumors (Fig. 2e).